Romark Overview
- Year Founded
-
1994
- Status
-
Out of Business
- Employees
-
128
- Latest Deal Type
-
Out of Business
- Financing Rounds
-
19
- Investments
-
1
Romark General Information
Description
Developer of molecules intended for treating infectious diseases and cancers. The company engages in the development and commercialization of small molecules that target cell signaling pathways that are dysregulated in pathological states for treating infectious diseases, cancers, and autoimmune diseases, enabling pharmaceutical companies to develop medicines for cancers and infectious diseases so that ultimately patients suffering from such diseases get relief and lead a healthy life.
Contact Information
Website
www.romark.comCorporate Office
- 4830 West Kennedy Boulevard
- Suite 600
- Tampa, FL 33609
- United States
Corporate Office
- 4830 West Kennedy Boulevard
- Suite 600
- Tampa, FL 33609
- United States
Romark Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Romark Comparisons
Industry
Financing
Details
Romark Competitors (8)
One of Romark’s 8 competitors is Helsinn Healthcare, a Corporation company based in Lugano, Switzerland.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Helsinn Healthcare | Corporation | Lugano, Switzerland | ||||
| Evoke Pharma | Formerly VC-backed | Solana Beach, CA | ||||
| Abeona Therapeutics | Corporation | Cleveland, OH | ||||
| Arcutis Biotherapeutics | Formerly VC-backed | Westlake Village, CA | ||||
| Ironwood Pharmaceuticals | Formerly VC-backed | Boston, MA |
Romark Patents
Romark Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2021333566-A1 | Use of thiazolides against coronaviruses | Inactive | 24-Aug-2020 | ||
| CA-3189487-A1 | Use of thiazolides against coronaviruses | Pending | 24-Aug-2020 | ||
| EP-4199923-A1 | Use of thiazolides against coronaviruses | Inactive | 24-Aug-2020 | ||
| US-20230330069-A1 | Use of thiazolides against coronaviruses | Inactive | 24-Aug-2020 | ||
| WO-2022046622-A1 | Use of thiazolides against coronaviruses | Inactive | 24-Aug-2020 | A61K31/426 |
Romark Signals
Romark Acquisitions (1)
Romark’s most recent deal was a Merger/Acquisition with Scienza Labs for . The deal was made on 17-Sep-2018.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Scienza Labs | 17-Sep-2018 | Merger/Acquisition | Laboratory Services (Healthcare) |
Romark FAQs
-
When was Romark founded?
Romark was founded in 1994.
-
Where is Romark headquartered?
Romark is headquartered in Tampa, FL.
-
What is the size of Romark?
Romark has 128 total employees.
-
What industry is Romark in?
Romark’s primary industry is Drug Discovery.
-
Is Romark a private or public company?
Romark is a Private company.
-
What is Romark’s current revenue?
The current revenue for Romark is .
-
How much funding has Romark raised over time?
Romark has raised $267M.
-
Who are Romark’s competitors?
Helsinn Healthcare, Evoke Pharma, Abeona Therapeutics, Arcutis Biotherapeutics, and Ironwood Pharmaceuticals are some of the 8 competitors of Romark.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process